Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$67K Hold
450
0.03% 135
2015
Q4
$73K Hold
450
0.04% 114
2015
Q3
$62K Buy
450
+250
+125% +$39.4K 0.03% 123
2015
Q2
$31K Hold
200
0.01% 163
2015
Q1
$32K Hold
200
0.01% 155
2014
Q4
$32K Hold
200
0.01% 155
2014
Q3
$28K Sell
200
-57
-22% -$7.44K 0.01% 155
2014
Q2
$30K Buy
257
+57
+29% +$6.6K 0.01% 156
2014
Q1
$25K Sell
200
-353
-64% -$42.8K 0.01% 163
2013
Q4
$63K Buy
553
+116
+27% +$13.2K 0.03% 197
2013
Q3
$49K Sell
437
-47
-10% -$5.1K 0.05% 120
2013
Q2
$48K Buy
+484
New +$50.2K 0.03% 198

Other funds holding AMGN

Hoxton Financial's AMGN Position: Q1 2016 in Review

Hoxton Financial held its Amgen (AMGN) position steady in Q1 2016 at 450 shares worth $67K. The position accounts for 0.03% of the portfolio, ranked #135.

Hoxton Financial first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $73K in Q4 2015. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Hoxton Financial held 450 shares of Amgen worth $67K as of Q1 2016.
  • Hoxton Financial left its Amgen share count unchanged in Q1 2016.
  • Amgen made up 0.03% of Hoxton Financial's portfolio in Q1 2016, its #135 holding.
  • Hoxton Financial first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Hoxton Financial's Amgen position peaked at $73K in Q4 2015.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.